← All trials
NCT04302519
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 5, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Jul 30, 2021
- First posted
- Mar 10, 2020
- Last posted
- Mar 10, 2020
- Enrollment
- 24
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CAR-T (Shanghai) Biotechnology Co.,Ltd.Lead sponsor
- Wuhan Renmin UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.